CAS: 2226534-49-0
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Y06137 REF: TM-T13363CAS: 2226534-49-0 | 97.27% | 60.00 €~669.00 € | Fri 21 Feb 25 | |
5-[1-(Cyclohexylmethyl)-6-[(3S)-3-methylmorpholin-4-yl]benzimidazol-2-yl]-3-methyl-1,2-benzoxazole REF: 3D-BPD53449CAS: 2226534-49-0 | Min. 95% | - - - | Discontinued product |
Y06137
CAS:2226534-49-0
Y06137, selective BET inhibitor, Kd 81 nM for BRD4(1), researched for castration-resistant prostate cancer treatment.
Formula:
C27H32N4O2
Purity:
97.27%
Color and Shape:
Solid
Molecular weight:
444.57
Ref: TM-T13363
1mg | 60.00 € | ||
2mg | 86.00 € | ||
5mg | 126.00 € | ||
10mg | 201.00 € | ||
25mg | 374.00 € | ||
1mL*10mM (DMSO) | 140.00 € |
Estimated delivery in United States, on Friday 21 Feb 2025
5-[1-(Cyclohexylmethyl)-6-[(3S)-3-methylmorpholin-4-yl]benzimidazol-2-yl]-3-methyl-1,2-benzoxazole
CAS:2226534-49-0
5-[1-(Cyclohexylmethyl)-6-[(3S)-3-methylmorpholin-4-yl]benzimidazol-2-yl]-3-methyl-1,2-benzoxazole is a ligand that specifically binds to the dopamine D2 receptor. It is also …
Formula:
C27H32N4O2
Purity:
Min. 95%
Molecular weight:
444.6 g/mol
Ref: 3D-BPD53449
1mg | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information |